{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:16:26Z","timestamp":1793837786502,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1418,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971869"],"award-info":[{"award-number":["81971869"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873944"],"award-info":[{"award-number":["81873944"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1186\/s13613-022-01033-5","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T23:11:38Z","timestamp":1659913898000},"page":"72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case\u2013control study"],"prefix":"10.1016","volume":"12","author":[{"given":"Jiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianghong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenliang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangxiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"TaoWang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-louis","family":"Teboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-022-01033-5_bb0010","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/cid\/ciy686","article-title":"Microbial etiology and prognostic factors of ventilator-associated pneumonia: a multicenter retrospective study in Shanghai","volume":"67","author":"Huang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-022-01033-5_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jgar.2016.12.016","article-title":"Epidemiology of multidrug-resistant gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients","volume":"9","author":"Gupta","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1186\/s13613-022-01033-5_bb0020","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1086\/653059","article-title":"End points in hospital-acquired pneumonia and\/or ventilator-associated pneumonia clinical trials: food and drug administration perspective","volume":"51","author":"Laessig","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1186\/s13613-022-01033-5_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1186\/s13613-022-01033-5_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/QCO.0000000000000720","article-title":"Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials","volume":"34","author":"Monsel","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1186\/s13613-022-01033-5_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-11-317","article-title":"A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Naesens","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1186\/s13613-022-01033-5_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1465-0691.2004.1004.x","article-title":"The need for new antibiotics","volume":"10","author":"Livermore","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1186\/s13613-022-01033-5_bb0045","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1097\/CCM.0000000000001539","article-title":"The role of aerosolized colistin in the treatment of hospital-acquired pneumonia: experience of multicenter from turkey","volume":"44","author":"Korkmaz Ekren P, Toreyin N, Sayiner A, Bacakoglu F, Colistin Study G","year":"2016","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-022-01033-5_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/CCM.0000000000000771","article-title":"The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis","volume":"43","author":"Valachis","year":"2015","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-022-01033-5_bb0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/microorganisms9061154","article-title":"Nebulized colistin in ventilator-associated pneumonia and tracheobronchitis: historical background pharmacokinetics and perspectives","volume":"9","author":"Zhu","year":"2021","journal-title":"Microorganisms"},{"issue":"2","key":"10.1186\/s13613-022-01033-5_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QCO.0000000000000633","article-title":"Optimizing aerosol delivery of antibiotics in ventilated patients","volume":"33","author":"Ehrmann","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1186\/s13613-022-01033-5_bb0065","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00134-020-06036-z","article-title":"Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis","volume":"46","author":"Fernando","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1186\/s13613-022-01033-5_bb0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1186\/s13613-022-01033-5_bb0075","doi-asserted-by":"crossref","first-page":"1413e1","DOI":"10.1016\/j.cmi.2020.01.026","article-title":"Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant gram-negative bacilli a multicentre study","volume":"26","author":"Tellapragada","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1186\/s13613-022-01033-5_bb0080","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1186\/s13613-022-01033-5_bb0085","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute dialysis quality initiative w acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"3","key":"10.1186\/s13613-022-01033-5_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/pcmr.12468","article-title":"Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study","volume":"29","author":"Mattos","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1186\/s13613-022-01033-5_bb0095","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1093\/cid\/ciy692","article-title":"The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: a multicenter prospective observational study in China","volume":"67","author":"Xie","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-022-01033-5_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCP.0000000000000160","article-title":"Ventilator-associated infection: the role for inhaled antibiotics","volume":"21","author":"Palmer","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1186\/s13613-022-01033-5_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00134-010-1863-z","article-title":"Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database","volume":"36","author":"Kohlenberg","year":"2010","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1186\/s13613-022-01033-5_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-009-9148-6","article-title":"Inhaled anti-infective agents: emphasis on colistin","volume":"38","author":"Michalopoulos","year":"2010","journal-title":"Infection"},{"issue":"1","key":"10.1186\/s13613-022-01033-5_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2478\/jccm-2020-0044","article-title":"The susceptibility of MDR-K pneumoniae to polymyxin B plus its nebulised form versus polymyxin B alone in critically Ill South Asian patients","volume":"7","author":"Hasan","year":"2021","journal-title":"J Crit Care Med"},{"key":"10.1186\/s13613-022-01033-5_bb0120","unstructured":"D Med. Chinese instruction of polymyxin B, for Injection Shanghai First Biochemical Pharmaceutical Co. Ltd China, 2017."},{"issue":"1","key":"10.1186\/s13613-022-01033-5_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/antibiotics8010031","article-title":"A review of the clinical pharmacokinetics of polymyxin B","volume":"8","author":"Avedissian","year":"2019","journal-title":"Antibiotics"},{"key":"10.1186\/s13613-022-01033-5_bb0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3389\/fphar.2020.00829","article-title":"Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of polymyxin B in Chinese patients with multidrug-resistant gram-negative bacterial infections","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1186\/s13613-022-01033-5_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1186\/s13613-022-01033-5_bb0140","doi-asserted-by":"crossref","first-page":"785893","DOI":"10.3389\/fphar.2021.785893","article-title":"Pharmacokinetic\/pharmacodynamic based breakpoints of polymyxin B for bloodstream infections caused by multidrug-resistant gram-negative pathogens","volume":"12","author":"Bian","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1186\/s13613-022-01033-5_bb0145","first-page":"e00211","article-title":"Aerosolized polymyxin B for treatment of respiratory tract infections: determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against pseudomonas aeruginosa in a mouse lung infection model","volume":"61","author":"Lin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-022-01033-5_bb0150","unstructured":"Critical Medicine Professional Committee of Chinese Research Hospital Association, Evidence-based and Translational Committee of Infectious Diseases, Chinese Society of Research Hospitals. Chinese expert consen-sus on polymyxins. Chinese Critical Care Medicine. 2019;31(10): 1194\u20131198. https:\/\/doi.org\/10.3760\/cma.j.issn.2095-4352.2019.10.003."},{"key":"10.1186\/s13613-022-01033-5_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2478\/jccm-2020-0044","article-title":"The susceptibility of MDR- K. pneumoniae to polymyxin B Plus Its nebulised form versus polymyxin B alone in critically Ill South Asian patients","volume":"7","author":"Hasan","year":"2021","journal-title":"J Crit Care Med"},{"issue":"2","key":"10.1186\/s13613-022-01033-5_bb0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jac\/dkh369","article-title":"Combination therapy with polymyxin b for the treatment of multidrug-resistant Gram-negative respiratory tract infections","volume":"54","author":"Sobieszczyk","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1186\/s13613-022-01033-5_bb0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chest.2016.09.004","article-title":"clinical predictors of hospital mortality differ between direct and indirect ARDS","volume":"151","author":"Luo","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1186\/s13613-022-01033-5_bb0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jcpt.12543","article-title":"Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process","volume":"42","author":"Mattos","year":"2017","journal-title":"J Clin Pharm Ther"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-022-01033-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:38:43Z","timestamp":1776670723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025006302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2110582025006302"],"URL":"https:\/\/doi.org\/10.1186\/s13613-022-01033-5","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-022-01033-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s) 2022. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"72"}}